{"id":828002,"date":"2025-02-18T13:12:46","date_gmt":"2025-02-18T19:12:46","guid":{"rendered":"https:\/\/newsycanuse.com\/index.php\/2025\/02\/18\/egypt-achieves-maturity-level-3-for-medicines-and-vaccines-regulation\/"},"modified":"2025-02-18T13:12:46","modified_gmt":"2025-02-18T19:12:46","slug":"egypt-achieves-maturity-level-3-for-medicines-and-vaccines-regulation","status":"publish","type":"post","link":"https:\/\/newsycanuse.com\/index.php\/2025\/02\/18\/egypt-achieves-maturity-level-3-for-medicines-and-vaccines-regulation\/","title":{"rendered":"Egypt Achieves Maturity Level 3 for Medicines and Vaccines Regulation"},"content":{"rendered":"
\n

The Egyptian Drug Authority (EDA) has attained<\/a> Maturity Level 3 (ML3) for both medicines and vaccines regulation on Saturday 20 December.<\/p>\n

This achievement makes Egypt the first country in Africa to achieve ML3 for both categories. The Maturity level 3 reflects<\/a> a stable, well-functioning, and integrated regulatory health system.<\/p>\n

This latest recognition builds upon Egypt\u2019s earlier success in March 2022, when it first achieved<\/a> ML3 for vaccine regulation.<\/p>\n

The WHO\u2019s Global Benchmarking Tool (GBT) evaluates national regulatory authorities against over 250 indicators, assessing key functions such as product authorization, market surveillance, and adverse event detection.<\/p>\n

Attaining ML3 signifies a stable and well-functioning regulatory system, essential for ensuring access to safe and effective medical products.<\/p>\n

Hanan Balkhy, WHO Regional Director for the Eastern Mediterranean Region, highlighted to Ahram Online<\/a> that this accomplishment underscores Egypt\u2019s dedication to strengthening its health system.<\/p>\n

\u201cBy achieving WHO maturity level 3 for vaccines and medicines regulation, Egypt has set a powerful example for the region and beyond,\u201d she stated.<\/p>\n

The EDA\u2019s success<\/a> stemmed from a rigorous benchmarking process that involved close collaboration with the WHO\u2019s regional and country offices.<\/p>\n

This evaluation utilized the WHO\u2019s GBT to assess the EDA\u2019s regulatory systems against over 250 indicators, focusing on essential functions such as product authorization and market surveillance.<\/p>\n

The process, completed in November 2024, confirmed<\/a> the EDA\u2019s adherence to high international standards, resulting in the attainment of Maturity Level 3 (ML3) for both medicines and vaccine regulation.<\/p>\n

Yukiko Nakatani, WHO Assistant Director-General for Access to Medicines and Health Products, noted<\/a> that this achievement recognizes Egypt\u2019s sustained investment in its health system and its commitment to maintaining high safety and quality standards for medicines.<\/p>\n

As the EDA Chairman, Ali El-Ghamrawy, pointed<\/a> out that these dual accreditations are expected to attract foreign investment into the Egyptian pharmaceutical market and enhance the global reputation of Egyptian medicines.<\/p>\n

He expressed<\/a> optimism that this recognition would lead to increased demand for Egyptian pharmaceuticals across Africa and the Arab world.<\/p>\n<\/p><\/div>\n

Belal Nawar
Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

The Egyptian Drug Authority (EDA) has attained Maturity Level 3 (ML3) for both medicines and vaccines regulation on Saturday 20 December. This achievement makes Egypt the first country in Africa to achieve ML3 for both categories. The Maturity level 3 reflects a stable, well-functioning, and integrated regulatory health system. This latest recognition builds upon Egypt\u2019s<\/p>\n","protected":false},"author":1,"featured_media":828003,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27878,28579],"tags":[14942,47619],"class_list":{"0":"post-828002","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-achieves","8":"category-egypt","9":"tag-achieves","10":"tag-egypt"},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts\/828002","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/comments?post=828002"}],"version-history":[{"count":0,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts\/828002\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/media\/828003"}],"wp:attachment":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/media?parent=828002"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/categories?post=828002"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/tags?post=828002"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}